Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BBIO
Stock Latest News
The Fly
BridgeBio initiated with a Buy at Truist
4h ago
BBIO
Premium
Stock Analysis & Ideas
These 2 Momentum Stocks Got a Bullish Nod — Here’s Why They Could Reach New Highs
6d ago
SY
BBIO
Premium
Ratings
BridgeBio Pharma’s Promising Diversification and High-Margin Opportunities Drive Buy Rating
6d ago
BBIO
Premium
The Fly
Rivian downgraded, PayPal upgraded: Wall Street’s top analyst calls
7d ago
H
MA
Premium
The Fly
BridgeBio price target raised to $56 from $53 at Leerink
7d ago
ALNY
BBIO
Premium
The Fly
BridgeBio price target raised to $68 from $63 at Piper Sandler
7d ago
BBIO
Premium
Ratings
Cautious Hold Rating for BridgeBio Pharma Amid Attruby Sales Focus and BBP-418 Regulatory Prospects
7d ago
BBIO
Premium
Ratings
BridgeBio Pharma’s Promising Prospects: Buy Rating Driven by BBP-418’s Potential in Rare Neuromuscular Disorder
7d ago
BBIO
Premium
Ratings
BridgeBio Pharma’s Growth Potential Highlighted by Positive Outlook on BBP-418 and FDA Support
7d ago
BBIO
Premium
The Fly
BridgeBio initiated with a Buy at Jefferies
7d ago
BBIO
Premium
Ratings
BridgeBio Pharma’s BBP-418: A Promising Investment in Groundbreaking LGMD2I/R9 Therapy
8d ago
BBIO
Premium
The Fly
BridgeBio price target raised to $67 from $58 at Citi
10d ago
BBIO
Premium
The Fly
Microsoft upgraded, Instacart initiated: Wall Street’s top analyst calls
12d ago
MS
CAT
Premium
The Fly
Oppenheimer upgrades BridgeBio on execution, data catalysts
12d ago
BBIO
Premium
The Fly
BridgeBio upgraded to Outperform from Perform at Oppenheimer
12d ago
BBIO
Premium
Company Announcements
BridgeBio Pharma Enters Royalty Purchase Agreement
19d ago
8K
BBIO
Premium
Ratings
Strategic Financial Maneuvers and Growth Potential: BridgeBio Pharma’s Path to Profitability
19d ago
BBIO
Premium
The Fly
BridgeBio raises $300M via parital capped monetization of European royalty
21d ago
BBIO
Premium
Market News
3 Best Stocks to Buy Now, 6/30/2025, According to Top Analysts
21d ago
UTZ
BBIO
Premium
Market News
3 Best Stocks to Buy Now, 6/26/2025, According to Top Analysts
25d ago
LLY
BBIO
Premium
The Fly
BridgeBio to host limb-girdle muscular dystrophy type 2I/R9 webinar
25d ago
BBIO
Premium
The Fly
BridgeBio price target raised to $54 from $50 at BofA
26d ago
BBIO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.